Immunodiagnostic Systems Agrees €23m Biocode Hycel Buy; Stocks Fell Back

Published: Aug 03, 2007

LONDON (SHARECAST) - Immunodiagnostic Systems fell back Friday after the diagnostic testing kit group said it has conditionally agreed to buy 99.93% of Biocode Hycel for €23m, or roughly £15.5m. The acquisition of the Belgian-French group, which develops, manufactures and distributes IVD instruments and reagents, will be partly funded by a placing of 5m shares at 240p.

Back to news